AJP - Regu Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 291: R1474-R1481, 2006. First published June 1, 2006; doi:10.1152/ajpregu.00129.2006
0363-6119/06 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/R1474    most recent
00129.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly, S. P.
Right arrow Articles by Peter, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, S. P.
Right arrow Articles by Peter, R. E.

COMPARATIVE AND EVOLUTIONARY PHYSIOLOGY

Prolactin-releasing peptide, food intake, and hydromineral balance in goldfish

Scott P. Kelly1,2 and Richard E. Peter2

1Department of Biology, York University, Toronto, Ontario, Canada; and 2Department of Biological Science, University of Alberta, Edmonton, Alberta, Canada

Submitted 22 February 2006 ; accepted in final form 24 May 2006


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
A potential role for prolactin-releasing peptide (PrRP) in appetite regulation and hydromineral balance in goldfish was examined. PrRP was found to be expressed in discrete regions of the goldfish brain, in particular, the hypothalamus. Intraperitoneal (IP) or intracerebroventricular administration of PrRP had dose-dependent effects to suppress food intake in goldfish. Hypothalamic PrRP mRNA expression significantly increased after feeding, as well as after 7 days of food deprivation. Refeeding fish after 7 days food deprivation did not result in a postprandial increase in PrRP mRNA expression. These data suggest an anorexigenic role for PrRP in the short term around a scheduled meal time, but not over the longer term. IP injection of PrRP significantly increased pituitary prolactin (PRL) mRNA levels, suggesting involvement in the regulation of lactotroph activity. Acclimating goldfish to an ion-poor environment decreased serum osmolality and increased PrRP and PRL mRNA levels, providing evidence for PrRP involvement in hydromineral balance through its actions on lactotrophs. Acclimation to ion-poor water diminished the anorexigenic properties of PrRP in goldfish, indicating that a role for PrRP in goldfish satiation is counterbalanced by alternate systemic needs (i.e., osmoregulatory). This was further supported by an ability to reinstate the anorexigenic actions of PrRP in fish acclimated to ion-poor water by feeding a salt-rich diet. These studies provide evidence that PrRP is involved in regulating appetite and hydromineral balance in fish, and that the degree of involvement in either process varies according to overall systemic needs in response to environmental conditions.

appetite; hypothalamus; osmoregulation; pituitary; lactotroph


PROLACTIN-RELEASING PEPTIDE (PrRP) was first described as an endocrine factor of hypothalamic origin by Hinuma et al. (9) who unified the endogenous ligand with an orphan G-protein-coupled receptor (hGR3/GPR10). These initial studies and subsequent reports have suggested PrRP to be a prolactin-releasing factor (PRF) in at least two groups within the chordate phylum, namely mammals (9, 17) and bony fishes (18, 23, 27). However, in mammals, the exact nature and efficacy of PrRP as a classic hypophysiotropic PRF remains unclear (for a review, see Ref. 32). However, the widespread distribution of PrRP in the central nervous system (CNS) suggests involvement in a number of functions (for a review, see Ref. 29). In bony fishes, PrRP was initially described as a novel bioactive peptide with an RFamide C-terminal (8). As is the case with mammalian PrRP, fish PrRP is widely distributed in brain tissue of species studied so far (18, 25, 36), and this also suggests involvement in multiple functions.

In mammals, PrRP mRNA, peptide, and receptor have been localized to areas of the CNS known to be involved in the regulation of energy balance and appetite control (11, 22). Such observations suggested a physiological role for PrRP in the regulation of energy homeostasis. Lawrence et al. (13) first reported alterations in PrRP mRNA expression that were consistent with an anorexigenic role for PrRP. In the same communication, intracerebroventricular injection of PrRP was reported to reduce food intake in both free-fed rats, as well as fasted, re-feeding animals (13). A number of additional reports support appetite regulation as one of several potential physiological roles for PrRP in mammals (6, 14, 15, 26). Much less is known about the potential appetite-regulating effects of PrRP in nonmammalian vertebrates. Recent studies have suggested that PrRP may be involved in both the regulation of feeding and energy metabolism in aves (30, 31), and anecdotal reports have introduced a scenario whereby PrRP "induction" in bony fish may result in poor growth (24). However, to the best of our knowledge, there are no published studies that address a potential role for PrRP in the regulation of food intake in fish.

In bony fishes, prolactin (PRL) has been reported to have a broad range of systemic effects (10). Of these actions, PRL is principally considered to affect epithelial barriers that control hydromineral balance in hypersomoregulating fish (for a review, see Ref. 16). With evidence suggesting PrRP to be an important PRL secretagogue in fish (18, 23, 27), observations that brain PrRP mRNA and pituitary PRL mRNA expression elevate in fish acclimated to freshwater (FW), relative to those acclimated to seawater, are consistent with the generally accepted actions of PRL as a "FW osmoregulatory hormone" and PrRP as a PRF under such conditions (24).

The objectives of the present studies were several-fold. First, we hypothesized that PrRP may possess appetite-regulating effects in fish. We addressed this by examining the effects of central and peripheral administration of PrRP on food intake in goldfish. Secondly, we hypothesized that PrRP would participate in regulatory mechanisms that control hydromineral balance in a stenohaline FW fish. To examine this, we acclimatized goldfish to a FW environment with lower ion content than "typical" FW. In the presence of an increased ionic/osmotic gradient between external (water) and internal (body fluids) environments (i.e., an increased demand on hyperosmoregulatory mechanisms), it was anticipated that the role of PRL as a "FW-adapting hormone," and, therefore the role of PrRP as a PRF, would be emphasized. Lastly, we sought to address how the role of PrRP as a potential PRF involved in osmoregulatory homeostasis and the role of PrRP as a potential appetite-regulating endocrine factor interacted in a physiologically relevant manner that facilitated both processes.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Experimental animals. All experiments were conducted on mixed sex common/comet variety goldfish (Carassius auratus). Fish (~30–35 g) were purchased from Mt. Parnell Fisheries (Mercersburg, PA) and held in 600-liter flow-through freshwater (FW) aquaria at 17°C under simulated natural photoperiod (Edmonton, AB, Canada; 53.34° N/113.25° W). Edmonton dechlorinated FW was of the following composition (in µM); 330 [Na+], 120 [Cl], 1100 [Ca2+], and 20 [K+]. During this period, fish were fed ad libitum once daily with commercial fish feed pellets (Corey Aquafeeds, Fredericton, NB, Canada). At least 2 wk before all experiments, fish were transferred to 65-liter flow-through glass aquaria at 20°C and fed a 2% wet body mass ration once daily at a scheduled feeding time (1000). All experiments were carried out according to the guidelines set out by the Canadian Council for Animal Care under the approval of the Biosciences Animal Service Unit, University of Alberta, Edmonton, Canada.

Cloning and sequence analysis of cDNA for prepro-goldfish PrRP. Goldfish were anesthetized in 0.05% tricainemethane sulfonate (MS 222; Syndel Laboratories, Vancouver, BC, Canada) and killed by spinal transection. Forebrain regions (telencephalon and hypothalamus) were removed and immersed in Trizol reagent (Invitrogen, Carlsbad, CA). Total RNA was extracted immediately from this tissue and Superscript II RNase H reverse transcriptase (Invitrogen) used for cDNA synthesis. To isolate goldfish prolactin-releasing peptide cDNA, primers PrRP1 (5'-CCT GTT ACT GAA GAG CAT ACG-3') and PrRP2 (5'-ATT ATA CAC GCT AAT ACA CC-3') were designed based on previously published sequence information for Japanese crucian carp RF-amide (PrRP) (25) and used for PCR amplification. The conditions for PCR were 5 min denaturation at 95°C followed by 35 cycles of denaturation at 95°C (1 min), annealing at 53°C (1 min), extension at 73°C (1 min), respectively and a final, single, extension cycle at 73°C for 10 min. The PCR product was separated by agarose gel electrophoresis, excised, then isolated using a Geneclean II kit (Bio 101, La Jolla, CA). The purified cDNA fragment was then subcloned using a pGEM-T Vector System I (Promega, Madison, WI). Plasmid DNA containing cDNA inserts was isolated and purified by alkaline lysis (1, 2) and sequenced (Applied Biosystems Automated Sequencer, Perkin Elmer, Norwalk, CT).

Detection of prepro-PrRP in goldfish tissues. Using the same primers and PCR conditions as described for the cloning of full-length cDNA encoding for prepro-PrRP, expression in discrete regions of the brain (olfactory bulbs, telencephalon, hypothalamus, midbrain, and hindbrain), and pituitary was examined using RT-PCR and Southern blot analysis. The reactions were electrophoresed, as previously described and transferred to a Hybond-N membrane (Amersham Biosciences, Baie d’Urfe, QB, Canada) by capillary transfer. A [{alpha}32P]dCTP-labeled probe covering the full-length PrRP cDNA was used for hybridization of membranes containing capillary transferred PCR product. Probe labeling was conducted using a rediPRIME II random prime labeling system (Amersham), and the labeled probe was purified to reduce nonspecific background signal using QIAquick spin columns (Qiagen, Santa Clarita, CA). Labeled membranes were exposed on a phosphorimaging screen (Molecular Dynamics, Sunnyvale, CA) for 1 h, after which the phosphorscreen was scanned using a Phosphorimager 445 SI (Molecular Dynamics). As an internal control, PCR for a partial fragment of goldfish beta-actin (GenBank accession number AF079831) was performed using the same cDNA generated from the tissues described above. These reactions were electrophoresed as previously described, and a gel image captured. Tissue distribution of prepro-PrRP was further examined using Northern blot analysis conducted on discrete regions of the goldfish brain (i.e., regions as described above). A total of 10 µg RNA from each brain region was electrophoresed in a denaturing agarose gel (1.5%) with formaldehyde after which, RNA was transferred to a Hybond-N membrane (Amersham Biosciences) by capillary transfer. Membranes were hybridized with full-length putative PrRP [{alpha}32P]dCTP-labeled probe, exposed on a phosphorimaging screen, and analyzed with a Phophorimager using a protocol identical to that described for Southern blot analysis except that exposure of the [{alpha}32P]dCTP-labeled membrane on the phosphorscreen was allowed to proceed for a period of 5 days. Northern blot membranes were then stripped and hybridized a second time using a partial fragment of [{alpha}32P]dCTP-labeled goldfish beta-actin.

Slot blot analysis of prepro-goldfish PrRP and pituitary PRL mRNA. Total RNA was extracted from hypothalamus and pituitary samples, as described previously. RNA samples were denatured [denaturing solution; 42% formamide, 1.6% 3-(N-morpholino)propanesulfonic acid, 2 M formaldehyde; 65°C for 15 min] and immobilized by vacuum suction onto Hybond-N membrane using a Bio-Dot SF blotting apparatus. Membranes were fixed by UV exposure. The amount of RNA used for quantifying mRNA expression of prepro-PrRP and pituitary PRL was qualified by constructing standard curves to establish signal density as a function of total RNA immobilized within each slot (data not shown). Total RNA used for each tissue was selected so as to fall in the midrange of the curve under normal (control) conditions, giving optimal resolution for experimentally induced modulation of transcript abundance (for details, see Ref. 5). For pituitary PRL mRNA analysis, a partial fragment (~700 bp) of [{alpha}32P]dCTP-labeled goldfish PRL cDNA (GenBank accession no. S82197) was generated using the techniques described above. The primer sequences used to amplify goldfish PRL cDNA were PRL1 (5'-GTT CTG ATG TGT GGG TTT G-3') and PRL2 (5'-TCT CTA ACA CAT CTC AGG TC-3'). The conditions for goldfish PRL cDNA PCR amplification were 5-min denaturation at 95°C followed by 30 cycles of denaturation at 95°C (1 min), annealing at 53°C (1 min), extension at 73°C (1 min), respectively, and a final, single, extension cycle at 73°C for 3 min.

PrRP administration and food intake. A 20-amino acid mature goldfish PrRP was synthesized according to the amino acid sequence deduced from the above analysis [SPEIDPFWYVGRGVRPIGRF-NH2]. PrRP was synthesized by solid-phase approach with Boc chemistry on a CS-Bio Peptide Synthesizer (Model CS536). The synthesis was performed on 4-methylbenzhydrylamine resin. The following amino acid side-chain protections were used: Arg(Tos), Asp(OcHex), Glu(OcHex), Ser (Bzl), and Thr(Bzl). The couplings were mediated with diisopropylcarbodiimide and N-hydroxybenzotriazole in dimethylformamide. Boc removal was achieved in 20 min with trifluoroacetic acid (80% in CH2Cl2, 1–2% m-cresol). The completed peptide was cleaved from the resin by anhydrous HF/anisole (9:1, vol/vol). The crude peptide was determined by analytical HPLC and capillary zone electrophoresis analysis and showed a purity of >95% by both methods. The observed monoisotopic (M + H)+ value of the peptide corresponded with the calculated (M + H)+ value (2347.2) determined by matrix-assisted laser desorption/ionization-mass spectrometry. For intraperitoneal injections, anesthetized fish were weighed, and an injection of goldfish PrRP administered through the ventrolateral side of the body wall using a Hamilton syringe. The volume of each injection varied according to fish body weight at 2.5 µl/g fish. Varying doses of PrRP were administered intraperitonially for determination of food intake and for determination of pituitary PRL mRNA expression. Fish that received intracerebroventricular injections were used for analysis of food intake only. Procedures for intracerebroventricular administration of goldfish PrRP were conducted according to methodology previously outlined (20, 33). Briefly, anesthetized fish were placed in a custom-designed stereotaxic apparatus, and varying doses of test solution were injected into the preoptic region of the brain third ventricle (coordinates +1.0, M, D 1.2), according to the stereotaxic atlas of the goldfish brain (20). The volume of injection varied relative to fish body weight at 0.034 µl/g fish mass. After intracerebroventricular injection, the cranial cavity was filled with teleost physiological saline (4). The skull flap was put back in place and secured with surgical thread. Fish were then placed in fresh water where they generally regained equilibrium within 2–5 min. After regaining equilibrium, fish were given a 10- to 15-min postoperative recovery period before conducting experiments to determine food intake. No mortality was observed as a result of the surgical procedures. Goldfish will feed immediately after a 10–15 min postoperative recovery period. Therefore food intake was determined 10–15 min after recovery from surgical anesthetic using fish held in pairs in a single observational tank. Each fish pair was administered the same treatment (i.e., untreated, saline, or PrRP dose). Fish were provided with a preweighed excess of pellets (approx. 4–5% body weight) and allowed to feed undisturbed for 1 h. During the first set of experiments, fish were observed directly so that individual food intake rates could be recorded. After 1 h of feeding, all remaining pellets were recovered and dried to a constant weight for the determination of dry pellet weight. Dry pellet weights were corrected for pellet weight lost to the water during the 1-h feeding period, and food intake was calculated by weight differences. From the direct observations of food intake, it was evident that each fish within a paired treatment ate approximately the same amount of food relative to body weight. This was confirmed by regression analysis using untreated and sham-treated groups, where food intake of fish 1 = 0.8756(fish 2) + 1.9468, r = 0.82, n = 24, P < 0.0001. From this point forward, fish were not observed. Instead, fish were allowed to feed undisturbed for 1 h, after which time, all remaining pellets were gathered, dried, and weighed. Using the weight differences (corrected for pellet weight lost to the water) the total amount of food eaten was calculated relative to the mass of the two fish combined.

PrRP administration and pituitary PRL expression. To examine whether PrRP had a stimulatory action on pituitary lactotrophs in goldfish, pituitary PRL mRNA expression was measured after IP administration of PrRP. A single injection of PrRP was administered to multiple groups of goldfish at doses effective in altering food intake (i.e., 25 and 250 ng/g body mass), and pituitaries were collected at times –1, 1, 2, 4, and 8 h preinjection and postinjection. As a control, saline was administered to a separate series of groups and pituitaries collected at identical time periods. PRL mRNA expression was analyzed in RNA samples extracted from individual pituitaries. PRL mRNA was examined using slot blot analysis, as previously outlined, and expressed relative to goldfish beta-actin after stripping and reprobing the same membranes.

Food deprivation and postprandial PrRP mRNA expression. To examine the effects of food deprivation on hypothalamic PrRP mRNA expression, fish were food deprived for periods of 3 and 7 days. Total RNA extracted from hypothalamic tissues was examined for alterations in PrRP mRNA expression using slot blot analysis, as described above. To examine postprandial responses of goldfish PrRP, hypothalamic PrRP mRNA expression was measured over a period of 24 h after a single feeding event. In these studies, two experimental regimes were used. The first regime comprised six groups of fish that were fed once daily at a scheduled time (for 2 wk) until sampling. The second comprised six groups of fish that were food deprived for 7 days and then fed a single meal. Temporal sampling of groups took place around the single feeding event at –1, 0, 3, 6, 12, and 24 h before and after feeding. In all cases, the single feeding event comprised a 2% body mass ration presented at time 0. PrRP mRNA expression in the hypothalamus was measured by slot-blot analysis, as previously described.

Acclimatization of goldfish to ion-poor water. Goldfish were acclimated to ion-poor FW by gradually replacing flow-through regular dechlorinated Edmonton FW with flow-through reverse osmosis water until a ratio of ~30:70% (regular dechlorinated FW: reverse osmosis water) was obtained. Fish were allowed to acclimate to these conditions for at least 3 wk. Water ion levels in ion-poor water were measured by atomic absorption spectrometry and were, in µM: 100 [Na+], 50 [Cl], 260 [Ca++], 8 [K+]. Tissues for mRNA analysis were collected and analyzed, as described previously. As well as tissues for mRNA analysis, blood was collected from these fish for analysis of serum osmolality. Blood was allowed to clot at room temperature, and serum was obtained after centrifugation. Osmolality was measured using a vapor pressure osmometer (Wescor).

PrRP and food intake in fish acclimatized to ion-poor water. Feeding studies in fish acclimatized to ion-poor water were conducted as outlined above. Only IP injections (the least invasive of techniques) were used to administer PrRP in these studies. In fish held in ion-poor conditions and fed salt-rich diets, diets were prepared by grinding commercial pellets to a powder and in diets designated for salt addition, adding NaCl before reconstituting powdered diets with distilled water into a paste. The paste was run through a commercial pasta maker to make moist "noodles" which were then dried in an oven at 40–45°C. Control diets were treated in an identical manner without the addition of NaCl. Fish used for salt-rich diet-feeding studies were fed salt-rich diets for 2 wk before study. Control diets had a nominal Na+ content of 0.6 g/100 g, whereas salt-rich diets had a nominal Na+ content of 6 g/100 g. Measured dietary Na+ content was 0.45 ± 0.01 g/100 g (n = 3) and 5.99 ± 0.04 g/100 g (n = 3) for control and salt-rich diets, respectively.

Statistical analysis. All data are expressed as mean values ± SE. Data were either subjected to a t-test or an ANOVA followed by a Student Neuman-Keuls multiple comparison test (Sigmastat software, Jandel Scientific, Richmond, CA) as appropriate. A fiducial level of P ≤ 0.05 was used throughout.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Goldfish prepro-PrRP cDNA. Analysis of PCR product amplified using primers PrRP1 and PrRP2 (see MATERIALS AND METHODS) by agarose gel electrophoresis revealed a single major band of ~450 bp. Sequence analysis indicated that this product was 466 bp in length comprising a 5'-untranslated region (54 bp), an open reading frame (351 bp), a stop codon (TGA), and a 3'-untranslated region (58 bp). The deduced amino acid sequence demonstrated the putative goldfish PrRP to be part of a 117-amino acid (aa) precursor with several potential cleavage recognition sites as outlined previously (25). By ClustalW analysis, the goldfish 117 aa precursor sequence was found to be identical to that of the previously characterized Japanese crucian carp (25).

PrRP expression profile. Expression of goldfish PrRP was investigated in discrete brain regions using RT-PCR and Southern blot analysis. All regions within the brain contained a transcript with the exception of the olfactory bulbs (Fig. 1A). The pituitary contained a weak positive signal. Northern blot analysis revealed an ~0.8-Kb band, and analysis of discrete brains regions suggested that transcript abundance was greatest in the hypothalamus, followed by the telencephalon. Signal was not detected in other regions of the brain or the pituitary by Northern blot analysis within the parameters used in our analysis.


Figure 1
View larger version (100K):
[in this window]
[in a new window]
 
Fig. 1. Brain distribution of goldfish prolactin-releasing peptide (gPrRP) (A) cDNA by RT-PCR and Southern blot analysis and (B) mRNA by Northern blot analysis. A,a: shows RT-PCR analysis of brain distribution. A,b: Southern blot of the same gel using a 32P-labeled probe for full-length PrRP. A,c: beta-actin PCR as an internal control for all cDNAs used. Different lanes represent the following: 1, positive control; 2, negative control; 3, olfactory bulbs; 4, telencephalon; 5, hypothalamus; 6, midbrain; 7, hindbrain; and 8, pituitary. B,a: Northern blot analysis of PrRP mRNA distribution in discrete regions of the brain and the pituitary. B,b: same membrane stripped and reprobed with beta-actin. Different lanes represent the following; 1, hindbrain; 2, midbrain; 3, hypothalamus; 4, telencephalon; 5, olfactory bulbs; and 6, pituitary.

 
PrRP administration and food intake. Goldfish exhibited a dose-dependent reduction in food intake in response to both intraperitoneal and intracerebroventricular injections of PrRP. Systemic administration (i.e., ip injection) of PrRP only reduced food intake at tested doses of 25 ng/g body wt and above (Fig. 2A). In contrast, central administration (i.e., icv injection) had a negative impact on food intake at lower doses, where a response could be seen after administration of PrRP at 5 ng/g body mass (Fig. 2B). At 10 ng/g body mass, the negative impact of PrRP on food intake was maximal, as increasing the dose to 25 ng/g body mass had no further effect.


Figure 2
View larger version (13K):
[in this window]
[in a new window]
 
Fig. 2. Food intake (mg food·g body wt–1·h–1) in goldfish after intraperitoneal (A) or intracerebroventricular (B) administration of PrRP at varying doses. Values are expressed as means ± SE (n = 10 – 12). Significant differences (P ≤ 0.05) between groups are denoted by different letters. Control fish were uninjected, and sham-treated fish were injected with saline.

 
Hypothalamus PrRP mRNA expression in response to food deprivation and feeding. Postprandial PrRP mRNA expression in the hypothalamus after a single feeding event differed between fed and food-deprived fish. In fish fed daily, PrRP mRNA expression increased after feeding, reaching a maximum at 6 h, which was significantly elevated relative to time 0 (Fig. 3A). In fish that were food deprived for 7 days before feeding a single meal, no variations in PrRP mRNA expression in the hypothalamus were found (Fig. 3B). In goldfish deprived of food for 3 days, no significant increase in hypothalamic PrRP mRNA expression was observed. However, after 7 days of food deprivation, a significant increase in PrRP mRNA expression was found (Fig. 4).


Figure 3
View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3. Effects of a single feeding event on postprandial hypothalamic PrRP mRNA expression in goldfish fed daily (A) or food deprived (B) for 7 days before feeding. Values are expressed as means ± SE (n = 8). Significant differences (P ≤ 0.05) between groups, determined relative to time 0 h, are denoted by an asterisk. No significant differences occurred in fish that were food deprived for 7 days before feeding.

 

Figure 4
View larger version (9K):
[in this window]
[in a new window]
 
Fig. 4. Hypothalamic PrRP mRNA expression in response to food deprivation. Fish were food deprived for a period of 3 or 7 days. Fed fish were fed once daily on a regular scheduled regimen. Values are expressed as means ± SE (n = 8). Significant differences (P ≤ 0.05) between a fed and unfed group within a time interval is denoted by an asterisk.

 
PrRP administration and pituitary PRL mRNA expression. Intraperitoneal injection of PrRP at doses consistent with those found to reduce food intake (i.e., 25 ng/g ip) resulted in significantly elevated pituitary PRL mRNA levels (Fig. 5, A and B). In the time course studied, data indicated that pituitary PRL mRNA expression did not significantly elevate above preinjection expression levels until 8 h after administration. Administration of 250 ng/g ip resulted in a significant elevation in pituitary PRL mRNA expression but not significantly different from that caused by the 25 ng/g ip injection.


Figure 5
View larger version (10K):
[in this window]
[in a new window]
 
Fig. 5. Alterations in goldfish pituitary PRL mRNA expression in response to PrRP administration. Multiple groups of goldfish were given either a single intraperitoneal injection of PrRP (25 or 250 ng/g body wt) or saline (control) and sampled at varying times after injection. A: temporal alterations in pituitary PRL mRNA expression in response to a 25 ng/g body wt dose. B: alterations in PRL mRNA expression were maximal at 8 h postinjection and compared for dose-dependent effects. In both treatments, PRL mRNA expression was significantly greater than preinjection values and PRL mRNA expression at equivalent time points after 8 h. No significant differences were observed between 25 and 250 ng/g body wt doses. Values are expressed as means ± SE (n = 8). Significant differences (P ≤ 0.05) between saline and corresponding PrRP-treated groups are denoted by an asterisk.

 
PrRP and PRL mRNA expression, serum osmolality, and food intake in fish acclimatized to ion-poor water. In fish acclimatized to ion-poor water, PrRP mRNA expression in the hypothalamus and pituitary PRL mRNA expression significantly increased (Fig. 6, B and C). As an overall indicator of hydromineral balance, serum osmolality significantly decreased in fish acclimatized to ion-poor conditions (Fig. 6A), indicating that elevated PrRP and PRL mRNA levels were in accord with greater demands on hypersomoregulatory mechanisms. Although an elevation in PrRP may be expected to elicit a reduction in food intake, as intraperitoneal and intracerebroventricular PrRP administration reduced food intake in our feeding experiments, a significant increase in food intake occurred in goldfish acclimatized to ion-poor conditions, as saline-injected fish consumed more food than saline-injected fish acclimatized to regular water (Fig. 7). Furthermore, administration of PrRP in fish acclimated to ion-poor conditions did not significantly reduce food intake at comparable doses (i.e., 25 ng/g body mass, see Fig. 7). At the highest doses tested (250 ng/g body mass), food intake was significantly reduced in fish acclimatized to both conditions. But at this high dose, food intake in fish acclimatized to ion-poor conditions was significantly greater than that found in fish held in regular water (Fig. 7). Feeding diets rich in salt to fish acclimatized to ion-poor water allowed us to dissect this apparent paradox further, as PrRP administration in these fish at a dose of 25 ng/g body mass, once again, significantly reduced food intake (Fig. 8). This was not the case in fish acclimatized to ion poor water and fed a regular (control) diet.


Figure 6
View larger version (9K):
[in this window]
[in a new window]
 
Fig. 6. Alterations in serum osmolality (A), pituitary PRL expression (B), and hypothalamic PrRP mRNA expression (C) after acclimatization of goldfish to ion-poor freshwater for 21 days. Values are expressed as means ± SE (n = 8). Significant differences (P ≤ 0.05) between groups are denoted by an asterisk.

 

Figure 7
View larger version (10K):
[in this window]
[in a new window]
 
Fig. 7. Food intake (mg food·g body wt–1·h–1) in goldfish acclimatized to either regular or ion-poor freshwater after intraperitoneal administration of PrRP at varying doses. Values are expressed as means ± SE (n = 10–12). Significant differences (P ≤ 0.05) between doses are denoted by different lower case (regular freshwater) and upper case (ion-poor freshwater) letters. Significant differences (P ≤ 0.05) between ion-poor and regular freshwater groups within a given treatment are denoted by an asterisk. Control fish were uninjected and sham-treated fish were injected with saline.

 

Figure 8
View larger version (9K):
[in this window]
[in a new window]
 
Fig. 8. Food intake (mg food·g body wt–1·h–1) in goldfish acclimatized to ion-poor freshwater after intraperitoneal administration of PrRP (25 ng/g body wt). Goldfish were fed either a regular diet (nominal Na+ content of 0.6 g/100 g) or a salt-rich diet (nominal Na+ content of 6 g/100 g). Values are expressed as means ± SE (n = 10–12). Significant differences (P ≤ 0.05) between groups are denoted by an asterisk.

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Results from cloning, sequence analysis, and expression analysis of goldfish prepro-PrRP are consistent with previous observations (25) that reported PrRP expression (using Southern blot analysis) within discrete brain regions with the exception of the olfactory bulbs. By Northern blot analysis of total RNA, our cDNA probe detected a single band, suggesting that the gene product produces a single transcript (Fig. 1B). Next, we hypothesized, on the basis of widespread brain distribution and hypothalamic presence (18, 25, 36; see RESULTS), that PrRP in bony fish would be involved in the regulation of appetite, as has been observed in mammals and aves (6, 13, 14, 26, 30, 31). Our findings support this hypothesis, as PrRP administration had dose-dependent, negative effects on food intake in goldfish. These observations are in line with the anorexigenic effects of PrRP in mammals but contrast with the effects seen in aves, where PrRP has been reported to stimulate appetite (30, 31).

Periprandial variations in mRNA expression of several appetite-regulating factors have been described in fish (for a review, see Ref. 35). In the current study, we observed a postprandial increase in hypothalamic PrRP mRNA expression. This is in accord with postprandial elevations in brain mRNA expression of other anorexigenic factors in fishes such as cholecystokinin (21) and cocaine- and amphetamine-regulated transcript (34). Conversely, under conditions of negative energy balance (i.e., 7 days of food deprivation) refed goldfish did not exhibit a postprandial increase in PrRP mRNA expression (Fig. 3B). These data indicate that when goldfish are food deprived, PrRP does not possess the same anorectic properties as when goldfish are in a state of positive energy balance. This response would seem intuitively adaptive, allowing fish to eat more to compensate for a period of food shortage/absence. However, in our interpretation of the postprandial changes in hypothalamic PrRP mRNA expression after a single feeding event in 7-day food deprived fish, we must also take into account changes in hypothalamic PrRP mRNA expression that occur in response to food deprivation itself. That is, goldfish that are food deprived for a period of 7 days exhibit a significant increase in hypothalamic PrRP mRNA expression (Fig. 4). This response appears atypical compared with other appetite-regulating neuropeptides in fish under similar conditions. For example, brain mRNA expression of neuropeptide Y, a potent appetite stimulant in goldfish, increased under conditions of food deprivation (19). In contrast, cocaine-amphetamine-regulated transcript, which has been demonstrated to reduce food intake in goldfish, exhibits a reduction in brain mRNA expression in response to food deprivation (34). However, although this is the first report on piscine PrRP gene expression in response to food deprivation, other studies have reported an elevation in circulating and pituitary PRL levels in fasted fish (37). Taken together, these observations suggest that PrRP may be involved in negatively regulating food intake in fish only in the short term and that increased PrRP mRNA expression after longer periods of food deprivation may be linked to other physiological processes. Peptide factors involved in the regulation of appetite and body weight can have short-term or long-term actions (28). The latter regulate body weight, whereas factors with short-term actions regulate the initiation and termination of feeding events. In mammals, PrRP has been suggested to exert its effect on energy homeostasis only in the short to medium term (7). Overall, our feeding studies and observations of PrRP mRNA expression in response to nutritional manipulation in goldfish are in general agreement with these views.

Our second objective was to address a potential role for PrRP in the maintenance of hydromineral balance in goldfish. To initiate this objective, we first established a correlate between PrRP and the activity of lactotrophs in goldfish by examining temporal alterations in pituitary PRL mRNA expression after PrRP administration. Previous studies have demonstrated that a single intraperitoneal injection of PrRP has significant and potent effects on PRL release in fish (18). Furthermore, PrRP administration not only increases PRL release but elevates pituitary PRL mRNA expression (23). In goldfish, a single intraperitoneal injection of PrRP also resulted in a significant increase in pituitary PRL mRNA expression (Fig. 5). These data support the idea that in goldfish, PrRP stimulates the secretion and synthesis of pituitary PRL, as it does in other fish species (18, 23, 27).

In bony fishes, PRL is often referred to as a "freshwater-adapting" hormone. Typically, circulating PRL levels in fish are higher in a hyposmotic environment (e.g., FW) than in a hyperosmotic environment (e.g., seawater). However, the ionic composition of FW can vary considerably under natural conditions, and an ion-poor FW environment will necessitate an increased involvement of endocrine factors such as PRL that regulate hyperosmoregulatory mechanisms. In a relatively ion-poor environment, goldfish serum osmolality decreased, whereas both hypothalamic PrRP mRNA expression and pituitary PRL mRNA expression increased. These observations support our hypothesis that PrRP participates in the regulation of hydromineral balance in goldfish (i.e., specifically hyperosmoregulatory mechanisms) as they are in general accord with the currently accepted role of PRL as an osmoregulatory hormone in fish (for a review, see Ref. 16). Furthermore, they parallel previous observations that reported higher brain PrRP and pituitary PRL mRNA expression in a euryhaline fish species acclimated to a hyposmotic environment relative to a hyperosmotic environment (24).

Our final objective was to examine whether the involvement of PrRP in appetite regulation and osmoregulation interacted in a physiologically relevant manner. Initial studies indicated that in goldfish 1) PrRP has anorexigenic properties and 2) PrRP is involved in hyperosmoregulation. These results seem inconsistent because increased PrRP in the CNS of fish acclimated to ion-poor FW may be expected to result in a potentially maladaptive reduction in food intake. This reduction in food intake would restrict the acquisition of dietary minerals as well as dietary energy. To address this paradox, we reexamined the effect of PrRP administration on food intake in fish acclimated to ion-poor FW. In fish acclimated to ion-poor FW, doses of PrRP that significantly reduced food intake in fish held in normal FW conditions did not reduce food intake (Fig. 7). This indicates that the anorexigenic actions of PrRP are diminished under conditions where osmoregulatory homeostasis requires a greater involvement of the PrRP-PRL system in maintaining hydromineral balance. Therefore, it would appear that we can observe a pattern of dual physiological function emerging that, in goldfish, is dependent on systemic demand for overall homeostatic control. Currently, there is no evidence that PrRP responds to hydromineral imbalance in mammals as hypothalamic PrRP and UHR1/GPR10 mRNA did not respond to salt loading in rats (12). Regardless, it seems of more importance to consider that vertebrate appetite, growth, and development is controlled by both internal factors (including the CNS, endocrine and neuroendocrine systems), as well as environmental factors. In goldfish, an environmentally induced chronic elevation of CNS PrRP may have necessitated a reorganization of mechanisms previously sensitive to the mediation of anorectic actions in favor of those that that are less sensitive to anorectic actions and instead favor osmoregulatory and/or energy acquisition needs. The exact nature of these mechanisms will require further investigation but could include PrRP receptor redistribution or upregulation of orexigenic circuitry. Of note, however, are the observations of Ellacott et al. (7) who reported that repeated intracerebroventricular injections of PrRP (via lateral cerebroventricular cannulas) in rats over a period of 5 days resulted in tolerance of experimental animals to the anorectic actions of PrRP. In the studies of Ellacot et al. (7), experimentally controlled repeated injections of PrRP represent a chronic elevation in brain PrRP levels. In our experiments, a chronic elevation in brain PrRP levels (as represented by increased hypothalamic mRNA levels) resulted from acclimatization to ion-poor FW conditions. In both cases, tolerance to the anorectic actions of PrRP appears to have occurred.

Of additional interest is that we were able to reestablish the sensitivity of goldfish to the anorectic actions of PrRP by feeding diets rich in salt to fish acclimated to ion-poor FW (Fig. 8). In fish acclimatized to ion-poor conditions and fed salt-rich diets for a period of 2 wk, the anorectic properties of PrRP doses found to negatively impact food intake in normal FW (25 ng/g) significantly reduced food intake. In contrast, at the same dose, no negative effects of PrRP on food intake were seen in control groups fed normal diets. In this regard, we hypothesize that the elevated PrRP and PRL mRNA (and presumably protein) levels in fish acclimated to dilute FW (e.g., see Fig. 6) will be lowered by feeding high-salt diets (i.e., by providing access to adequate salt through a dietary route despite low-water ion content). In the absence of elevated PrRP levels needed to maintain hydromineral balance, we propose that sensitivity to the anorectic actions of PrRP is restored. To confirm this hypothesis, further experimental analysis will be required. However, we have observed that fish held in a normal FW environment and fed diets rich in salt exhibit lower hypothalamic PrRP and pituitary PRL mRNA expression after 14 days (unpublished observations).

To summarize, we have demonstrated a potential involvement of PrRP in the negative regulation of food intake in goldfish and provided further evidence that in fishes, PrRP responds to environmental change. We propose that the effects of PrRP on appetite regulation in goldfish may occur in the short term and not the long term and that chronic elevations in brain PrRP, such as those occurring in fish acclimatized to ion-poor FW, appear to diminish the appetite-reducing effects of exogenously administered PrRP. These observations provide an impetus for further studies that consider how environmental conditions may alter the appetite-regulating effects of endocrine factors in the fish CNS.


    GRANTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
These studies were supported by NSERC operating grants to R. E. Peter and S. P. Kelly.


    ACKNOWLEDGMENTS
 
PrRP was synthesized and characterized in the Salk Institute by Dr. Judit Erchegyi and provided by Dr. Jean Rivier with NIH support HD-39899. We would like to thank Xin Wei Lin for advice on cloning and sequence analysis of goldfish PrRP and Helene Volkoff for outlining intracerebroventricular administration protocols.


    FOOTNOTES
 

Address for reprint requests and other correspondence: S. P. Kelly, Dept. of Biology, York Univ., Toronto, Ontario, Canada M3J 1P3 (e-mail: spk{at}yorku.ca)

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. Birnboim HC. A rapid alkaline extraction method for the isolation of plasmid DNA. Methods Enzymol 100: 243–255, 1983.[Web of Science][Medline]
  2. Birnboim HC and Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 7: 1513–1523, 1979.[Abstract/Free Full Text]
  3. Boeuf G and Payan P. How should salinity influence fish growth? Comp Biochem Physiol C 130: 411–423, 2001.
  4. Burnstock G. Saline for fresh-water fish. J Physiol 141: 35–45, 1958.[Free Full Text]
  5. Canosa LF, Lin X, and Peter RE. Regulation of expression of somatostatin genes by sex steroid hormones in goldfish brain. Neuroendocrinology 76: 8–17, 2002.[CrossRef][Web of Science][Medline]
  6. Ellacott KLJ, Lawrence CB, Rothwell NJ, and Luckman SM. PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Endocrinology 143: 368–374, 2002.[Abstract/Free Full Text]
  7. Ellacott KLJ, Lawrence CB, Pritchard LE, and Luckman SM. Repeated administration of the anorectic factor prolactin-releasing peptide leads to tolerance to its effects on energy homeostasis. Am J Physiol Regul Integr Comp Physiol 285: R1005–R1010, 2003.[Abstract/Free Full Text]
  8. Fujimoto M, Takeshita K, Wang X, Takabatake I, Fujisawa Y, Teranishi H, Ohtani M, Muneoka Y, and Ohta S. Isolation and characterization of a novel bioactive peptide, Carassius RFamide (C-RFa), from the brain of the Japanese crucian carp. Biochem Biophys Res Commun 242: 436–440, 1998.[CrossRef][Web of Science][Medline]
  9. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, and Fujino M. A prolactin-releasing peptide in the brain. Nature 393: 272–276, 1998.[CrossRef][Medline]
  10. Hirano T. The spectrum of prolactin actions in teleosts. In: Comparative Endocrinology: Developments and Directions, edited by Ralph CL. New York: Alan R. Liss, p. 53–74, 1986.
  11. Ibata Y, Iijima N, Katada Y, Kakihara K, Tanaka M, Hosoya M, and Hinuma S. Morphological survey of prolactin-releasing peptide and its receptor with special reference to their functional roles in the brain. Neurosci Res 38: 223–230, 2000.[CrossRef][Web of Science][Medline]
  12. Kalliomäki ML and Panula P. Neuropeptide FF, but not prolactin-releasing peptide, mRNA is differentially regulated in the hypothalamic and medullary neurons after salt loading. Neuroscience 124: 81–87, 2004.[CrossRef][Web of Science][Medline]
  13. Lawrence CB, Celsi F, Brennand J, and Luckman SM. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nature Neurosci 3: 645–646, 2000.[CrossRef][Web of Science][Medline]
  14. Lawrence CB, Ellacott KLJ, and Luckman SM. PRL-releasing peptide reduces food intake and may mediate satiety signaling. Endocrinology 143: 360–367, 2002.[Abstract/Free Full Text]
  15. Lawrence CB, Liu YL, Stock MJ, and Luckman SM. Anorectic actions of prolactin-releasing peptide are mediated by corticotrophin-releasing hormone receptors. Am J Physiol Regul Integr Comp Physiol 286: R101–R107, 2004.[Abstract/Free Full Text]
  16. Manzon L. The role of prolactin in fish osmoregulation: A review. Gen Comp Endocrinol 125: 291–310, 2002.[CrossRef][Web of Science][Medline]
  17. Matsumoto H, Noguchi J, Horikoshi Y, Kawamata Y, Kitada C, Hinuma S, Onda H, Nishimura O, and Fujino M. Stimulation of prolactin release by prolactin-releasing peptide in rats. Biochem Biophys Res Commun 259: 321–324, 1999.[CrossRef][Web of Science][Medline]
  18. Moriyama S, Ito T, Takahashi A, Amano M, Sower SA, Hirano T, Yamamori K, and Kawauchi H. A homolog of mammalian PRL-releasing peptide (fish arginyl-phenylalanyl-amide peptide) is a major hypothalamic peptide of PRL release in teleost fish. Endocrinology 143: 2071–2079, 2002.[Abstract/Free Full Text]
  19. Narnaware YK, Peyon PP, and Peter RE. Regulation of food intake by neuropeptide Y in goldfish. Am J Physiol Regul Integr Comp Physiol 279: R1025–R1034, 2000.[Abstract/Free Full Text]
  20. Peter RE and Gill VE. A stereotaxic atlas and technique for forebrain nuclei of the goldfish, Carassius auratus. J Comp Neurol 159: 69–101, 1975.[CrossRef][Web of Science][Medline]
  21. Peyon P, Saied H, Lin X, and Peter RE. Postprandial, seasonal and sexual variations in cholecystokinin gene expression in goldfish brain. Brain Res Mol Brain Res 74: 190–196, 1999.[Medline]
  22. Roland BL, Sutton SW, Wilson SJ, Luo L, Pyati J, Huvar R, Erlander MG, and Lovenberg TW. Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery. Endocrinology 140: 5736–5745, 1999.[Abstract/Free Full Text]
  23. Sakamoto T, Agustsson T, Moriyama S, Itoh T, Takahashi A, Kawauchi H, Björnsson Th B, and Ando M. Intra-arterial injection of prolactin-releasing peptide elevates prolactin gene expression and plasma prolactin levels in rainbow trout. J Comp Physiol [B] 173: 333–337, 2003.[CrossRef][Medline]
  24. Sakamoto T, Amano M, Hyodo S, Moriyama S, Takahashi A, Kawauchi H, and Ando M. Expression of prolactin-releasing peptide and prolactin in the euryhaline mudskippers (Periophthalmus modestus): prolactin-releasing peptide as a primary regulator of prolactin. J Mol Endocrinol 34: 825–834, 2005.[Abstract/Free Full Text]
  25. Satake H, Minakata H, Wang X, and Fujimoto M. Characterization of a cDNA encoding a precursor of Carassius RFamide, structurally related to a mammalian prolactin-releasing peptide. FEBS Lett 446: 247–250, 1999.[CrossRef][Web of Science][Medline]
  26. Seal LJ, Small CJ, Dhillo WS, Stanley SA, Abbott CR, Ghatei MA, and Bloom SR. PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. Endocrinology 142: 4236–4243, 2001.[Abstract/Free Full Text]
  27. Seale AP, Tioh T, Moriyama S, Takahashi A, Kawauchi H, Sakamoto T, Fujimoto M, Riley LG, Hirano T, and Grau EG. Isolation and characterization of a homologue of mammalian prolactin-releasing peptide from tilapia brain and its effect on prolactin release form the tilapia pituitary. Gen Comp Endocrinol 125: 328–339, 2002.[CrossRef][Web of Science][Medline]
  28. Stanley S, Wynne K, McGowan B, and Bloom S. Hormonal regulation of food intake. Physiol Rev 85: 1131–1158, 2005.[Abstract/Free Full Text]
  29. Sun B, Fujiwara K, Adachi S, and Inoue K. Physiological roles of prolactin-releasing peptide. Regul Pept 126: 27–33, 2005.[CrossRef][Web of Science][Medline]
  30. Tachibana T, Saito S, Tomonaga S, Takagi T, Saito ES, Nakanishi T, Koutoku T, Tsukuda A, Ohkubo T, Boswell T, and Furuse M. Effect of central administration of prolactin-releasing peptide on feeding in chicks. Physiol Behav 80: 713–719, 2004.[CrossRef][Medline]
  31. Tachibana T, Tsukuda A, Fujimoto M, Takahashi H, Ohkubo T, Boswell T, and Furuse M. Comparison of mammalian prolactin-releasing peptide and Carassius RFamide for feeding behaviour and prolactin secretion in chicks. Gen Comp Endocrinol 144: 264–269, 2005.[CrossRef][Web of Science][Medline]
  32. Taylor MM and Samson WK. The prolactin releasing peptides: RF-amide peptides. Cell Mol Life Sci 58: 1206–1215, 2001.[CrossRef][Web of Science][Medline]
  33. Volkoff H, Bjorklund JM, and Peter RE. Stimulation of feeding behaviour and food consumption in the goldfish, Carassius auratus, by orexin-A and orexin-B. Brain Res 846: 204–209, 1999.[CrossRef][Web of Science][Medline]
  34. Volkoff H and Peter RE. Characterization of two forms of cocaine- and amphetamine-regulated transcript (CART) peptide precursors in goldfish: molecular cloning and distribution, modulation of expression by nutritional status, and interactions with leptin. Endocrinology 142: 5076–5088, 2001.[Abstract/Free Full Text]
  35. Volkoff H, Canosa LF, Unniappan S, Cerda-Reverter JM, Bernier NJ, Kelly SP, and Peter RE. Neuropeptides and the control of food intake in fish. Gen Comp Endocrinol 142: 3–19, 2005.[CrossRef][Web of Science][Medline]
  36. Wang X, Morishita F, Matsushima O, and Fujimoto M. Immunohistochemical localaization of C-RFamide, a FMRF-related peptide, in the brain of the goldfish, Carassius auratus. Zool Sci 17: 1067–1074, 2000.[Medline]
  37. Weber GM and Grau EG. Changes in serum concentrations and pituitary content of the two prolactins and growth hormone during the reproductive cycle in female tilapia, Oreochromis mossambicus, compared with changes during fasting. Comp Biochem Physiol 124C: 323–335, 1999.




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/R1474    most recent
00129.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelly, S. P.
Right arrow Articles by Peter, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelly, S. P.
Right arrow Articles by Peter, R. E.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.